What end of Eli Lilly's weight-loss drug shortage means for the competition
The FDA confirmed Thursday that Eli Lilly has increased production of its blockbuster weight-loss drug Zepbound and type 2 ...
End of Zepbound Shortage Threatens $1 Billion Knockoff Weight-Loss Shot Industry
Americans who turned to telehealth companies and compounding pharmacies for cheap versions of Eli Lilly & Co.’s weight-loss ...
Hoping to get Mounjaro on the NHS? Millions may miss out on King Kong weight loss jab because of health chiefs' BIG mistake, say experts
In a consultation the UK's drugs watchdog has now proposed the NHS expands its use for weight loss for those who are severely ...
Night Helper Blog LLC on MSN2h
Yara GLP-1 Treatment: My Personal Review and Why I Recommend It for Lasting Weight Loss
Image credit Weight loss is an incredible journey; if you’ve been through it, you know how frustrating and overwhelmin ...
England's NHS Proposes Phased Rollout of Eli Lilly's Mounjaro, Considers Digital Services to Boost Access
NHS England has proposed a phased rollout of tirzepatide, a promising weight-loss drug, to benefit patients most likely to ...
BioSpace3h
Obesity Drug Shortage Ends for Lilly, Continues for Novo as Industry Bolsters Manufacturing
Scaling GLP-1 manufacturing capacity remains a key priority for the pharma industry, to help supply catch up with the ...
Today's Stocks on Sale: HIMS and More
Bearish investors decided to classify Hims & Hers Health (HIMS) as an obesity drug supplier. HIMS stock lost 9.6% on Thursday after the U.S. Food and Drug Administration said that GLP-1, made by Eli ...
NHS proposes phased launch for Eli Lilly’s Mounjaro
The roadmap suggests those with the greatest clinical need will get priority access, according to the NHS national medical ...
pharmaphorum5h
Mounjaro and Zepbound shortages over, declares FDA
The US Food and Drug Administration (FDA) has declared an end to the shortage of tirzepatide, the active ingredient in Eli ...
Jobs and Oil Prices Are Keeping Markets on Edge
Friday’s jobs report could bolster the view that the American economy is holding steady, but an oil price shock could ...
National Health Executive5h
Mounjaro: NICE consults on NHSE proposals for ’unprecedented’ obesity drug roll-out
Tirzepatide was granted approval from the Medicines and Healthcare products Regulatory Agency last November, while NICE ...
The Pharma Letter6h
NHS England plans phased obesity drug launch
NHS England has proposed a phased rollout of Eli Lilly’s obesity injection Mounjaro (tirzepatide), prioritizing patients with ...